Betterchem
Health     Drug Information     DMFs     Portal     21CFR     Search     Site Map

 
FDA Warning Letters citing this API.

 

This API's Main News Page.
 

 

FDA Approval Activities for this Drug…

Bupropion Hydrochloride Extended-Release Tablets, 100 and 150 mg, Eon Labs Manufacturing, ANDA 75-932 1/24/02 4/10/03 Bupropion Hydrochloride Tablets, 75 mg and 100 mg, Eon Labs Manufacturing, ANDA 75-613 10/10/00 11/7/00 12/5/01 Bupropion Hydrochloride Tablets, 75 mg and 100 mg, Invamed ANDA 75-584 2/7/00 2/11/00 6/7/01 Bupropion Hydrochloride Tablets, 75 mg and 100 mg, Mylan ANDA 75-491 Wellbutrin (bupropion hydrochloride) Immediate-Release & Sustained-Release Tablets, GlaxoSmithKline NDA 18-644/S-026 & 20-358/S-029 10/22/02 10/28/02 Wellbutrin (bupropion hydrochloride) Immediate-Release & Sustained-Release Tablets, 75 mg and 100 mg & 100 mg and 150 mg respectively GlaxoSmithKline NDA 18-644/S-022/S-024 & 20-358/S-018/S-024 10/2/02 10/2/02 Wellbutrin (bupropion hydrochloride) Immediate-Release & Sustained-Release Tablets, 75 mg and 100 mg & 100 mg and 150 mg respectively Glaxo SmithKline NDA 18-644/S-022/S-023 & 20-358/S-018/S-023 6/20/02 6/24/02 Wellbutrin SR (bupropion hydrochloride) Sustained-Release Tablets, 100 & 150 mg, GlaxoSmithKline NDA 20-358/S28 7/12/02 7/15/02 Wellbutrin SR (bupropion hydrochloride) Sustained-Release Tablets, Glaxo Wellcome NDA 20-358/S27 6/14/02 6/17/02 6/14/02 Wellbutrin SR (bupropion hydrochloride) Sustained-Release Tablets, 100 & 150 mg Glaxo Wellcome NDA 20-358/S25 2/13/02 Wellbutrin SR (bupropion hydrochloride) Sustained-Release Tablets, 100 & 150 mg Glaxo Wellcome NDA 20-358/S19 6/11/01 11/6/01 11/6/01 11/28/01 Wellbutrin XL (bupropion hydrochloride) Extended-Release Tablets, GlaxoSmithKline NDA 21-515 8/28/03 09/09/03 Wellbutrin (bupropion hydrochloride) Tablets GlaxoSmithKline NDA 18644/SCM-025 Zyban (bupropion hydrochloride) Sustained-Release Tablets, GlaxoSmithKline NDA 20-711/S13, S14, S16 & S18 2/14/03 2/25/03 2/25/03 Zyban (bupropion hydrochloride) extended-release tablets. GlaxoSmithKline NDA 20-711/S-015 2/21/02 2/21/02 Zyban (bupropion hydrochloride) Sustained-Release Tablets, GlaxoSmithKline NDA 20-711/S-012 BUPROPION HYDROCHLORIDE Tablet, Extended Release; 100MG WELLBUTRIN SR GLAXOSMITHKLINE 020358 BUPROPION HYDROCHLORIDE Tablet, Extended Release; 150MG WELLBUTRIN SR GLAXOSMITHKLINE 020711 BUPROPION HYDROCHLORIDE Tablet, Extended Release; 150MG ZYBAN GLAXOSMITHKLINE 020358 BUPROPION HYDROCHLORIDE Tablet, Extended Release; 200MG WELLBUTRIN SR GLAXOSMITHKLINE 020358 BUPROPION HYDROCHLORIDE Tablet, Extended Release; 50MG WELLBUTRIN SR GLAXOSMITHKLINE 021515 BUPROPION HYDROCHLORIDE Tablet, Extended Release; 150MG WELLBUTRIN XL SMITHKLINE BEECHAM 021515 BUPROPION HYDROCHLORIDE Tablet, Extended Release; 300MG WELLBUTRIN XL SMITHKLINE BEECHAM 075613 BUPROPION HYDROCHLORIDE Tablet; 100MG BUPROPION HCL Eon 075613 BUPROPION HYDROCHLORIDE Tablet; 75MG BUPROPION HCL Eon 075584 BUPROPION HYDROCHLORIDE Tablet; 100MG BUPROPION HCL Geneva TECH 075584 BUPROPION HYDROCHLORIDE Tablet; 75MG BUPROPION HCL Geneva TECH 018644 BUPROPION HYDROCHLORIDE Tablet; 100MG WELLBUTRIN GLAXOSMITHKLINE 018644 BUPROPION HYDROCHLORIDE Tablet; 75MG WELLBUTRIN GLAXOSMITHKLINE 075491 BUPROPION HYDROCHLORIDE Tablet; 100MG BUPROPION HCL Mylan 075491 BUPROPION HYDROCHLORIDE Tablet; 75MG BUPROPION HCL Mylan 075310 BUPROPION HYDROCHLORIDE Tablet; 100MG BUPROPION HCL Teva 075310 BUPROPION HYDROCHLORIDE Tablet; 75MG BUPROPION HCL Teva Bupropion Hydrochloride Extended-Release Tablets, Eon Labs Bupropion Hydrochloride Extended-Release Tablets, Impax Laboratories Bupropion Hydrochloride Extended-Release Tablets, Eon Labs Bupropion Hydrochloride Extended-Release Tablets, Impax Laboratories Wellbutrin SR (bupropion hydrochloride) Sustained-Release Tablets, GlaxoSmithKline Bupropion Hydrochloride Extended-release Tablets, Impax Laboratories Wellbutrin Immediate Release Tablets, GlaxoSmithKline Wellbutrin SR (bupropion hydrochloride) Sustained-Release Tablets, GlaxoSmithKline Wellbutrin XL (bupropion hydrochloride) Extended-Release Tablets, GlaxoSmithKline | Wellbutrin XL (bupropion hydrochloride) Extended-Release Tablets, GlaxoSmithKline, Labeling Revision | ZYBAN (bupropion hydrochloride), GlaxoSmithKline, Labeling Revision | Bupropion Hydrochloride Extended-Release Tablets, Impax Labs, Approval | Wellbutrin Immediate Release Tablets, GlaxoSmithKline, Labeling Revision | Wellbutrin SR (bupropion hydrochloride) Sustained-Release Tablets, GlaxoSmithKline, Labeling Revision | Wellbutrin XL (bupropion hydrochloride) Extended-Release Tablets, GlaxoSmithKline, Labeling Revision | Zyban (bupropion hydrochloride) Sustained-Release Tablets, GlaxoSmithKline, Labeling Revision

For the most up-to-date approval information, please locate this API using the drug index.


 

Other APIs… A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U-Z

Find API by Brand Name | Health | DMF Index | 21 CFR | Federal Register | Home Page | Site Map

 

 

 

© 2007 Betterchem Corp.